Nyctea Technologies was founded in 2020 by PhD student Gustav Ferrand-Drake del Castillo and his supervisor professor Andreas Dahlin at Chalmers University of Technology in Sweden.
Their research was initially focused on fundamental science, aimed to improve the understanding of polyelectrolyte brushes and their interactions with proteins. Scientific advances made during Gustav's PhD studies resulted in a method for unprecedented control of interactions between polyelectrolyte brushes and biomolecules by electrochemical signals. This resulted in a discovery of a new, susistanable and yield efficient application that will allow for separation and purification of biomolecules.
Our mission is to lower the cost and increase the speed of production of biological pharmaceuticals and to accelerate the development of the next generation of medical treatments.